OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new daily pill, NKT3447, in 23 adults with advanced solid tumors (like ovarian, endometrial, or lung cancer) that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was stopped early, so r…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 00:41 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors (like ovarian, breast, lung, and others). The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
Ovarian cancer drug trial halted: niraparib vs chemo showdown ends early
Disease control TerminatedThis study aimed to see if the drug niraparib works better than standard chemotherapy before surgery for people with advanced (stage III/IV) ovarian cancer that has a specific genetic feature called HRd. The trial was stopped early after enrolling 36 participants. Researchers mea…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 17, 2026 00:29 UTC